Company research
Burning Rock Biotech Ltd
CIK 1792267Updated Sep 26, 2026
SecurityBNR · NASDAQ · adr
BNR price & chart
Loading TradingView…
NASDAQ:BNR on TradingView ↗In the news
No coverage from other publishers is available.
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 117,312,000Source | 121,288,000Source | 146,482,000Source | 230,162,000Source |
| Property, Plant and Equipment, NetUSD | 4,447,000Source | 6,460,000Source | 18,579,000Source | 36,512,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 41,000Source | 58,000Source | 136,000Source | 288,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 68,409,000Source | 71,219,000Source | 86,634,000Source | 131,278,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 24,254,000Source | 20,826,000Source | 17,868,000Source | 15,942,000Source |
| Inventory, NetUSD | 6,946,000Source | 8,580,000Source | 9,721,000Source | 18,895,000Source |
| Assets, CurrentUSD | 105,616,000Source | 106,397,000Source | 124,523,000Source | 182,504,000Source |
| Operating Lease, Right-of-Use AssetUSD | 6,117,000Source | 7,287,000Source | 1,730,000Source | 6,989,000Source |
| Other Assets, NoncurrentUSD | 1,091,000Source | 1,086,000Source | 718,000Source | 3,029,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 40,770,000Source | 41,714,000Source | 38,253,000Source | 62,218,000Source |
| Stockholders’ equity: | ||||
| Additional Paid in CapitalUSD | 716,429,000Source | 685,306,000Source | 683,015,000Source | 664,442,000Source |
| Retained Earnings (Accumulated Deficit)USD | -608,544,000Source | -575,433,000Source | -542,773,000Source | -463,949,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -23,185,000Source | -21,652,000Source | -22,751,000Source | -24,027,000Source |
| Stockholders' Equity Attributable to ParentUSD | 76,542,000Source | 79,574,000Source | 108,229,000Source | 167,944,000Source |
| Liabilities and EquityUSD | 117,312,000Source | 121,288,000Source | 146,482,000Source | 230,162,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 35,318,000Source | 36,484,000Source | 37,095,000Source | 59,655,000Source |
| Operating Lease, Liability, CurrentUSD | 2,397,000Source | 3,366,000Source | 1,216,000Source | 5,399,000Source |
| Accounts Payable, CurrentUSD | 5,826,000Source | 4,623,000Source | 2,544,000Source | 7,387,000Source |
| Operating Lease, Liability, NoncurrentUSD | 3,497,000Source | 3,802,000Source | 520,000Source | 1,965,000Source |
| Other Liabilities, NoncurrentUSD | 1,712,000Source | 1,428,000Source | 638,000Source | 598,000Source |
| Additional Financial Items | ||||
| Deferred Revenue, CurrentUSD | 15,418,000Source | 16,152,000Source | 18,386,000Source | 21,405,000Source |
| Short-term InvestmentsCNY | — | — | — | 0Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -7,916,000Source | -47,489,000Source | -92,070,000Source | -140,815,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 3,112,000Source | 7,151,000Source | 18,789,000Source | 17,992,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 1,984,000Source | 21,320,000Source | 36,722,000Source | 47,379,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 4,430,000Source | 4,470,000Source | 1,745,000Source | 3,118,000Source |
| Increase (Decrease) in InventoriesUSD | -357,000Source | -344,000Source | -8,067,000Source | 3,140,000Source |
| Deferred Income Tax Expense (Benefit)CNY | 0Source | 0Source | 0Source | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -4,068,000Source | -12,640,000Source | -36,026,000Source | -66,232,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -628,000Source | -604,000Source | -1,309,000Source | -1,082,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 751,000Source | 742,000Source | 1,141,000Source | 8,994,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 272,000Source | -10,000Source | -6,878,000Source | -12,504,000Source |
| Repayments of Long-term DebtUSD | 14,000Source | — | 0Source | 0Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -5,873,000Source | -12,748,000Source | -43,670,000Source | -74,501,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 68,795,000Source | 71,536,000Source | 86,651,000Source | 134,151,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 4,000Source | 0Source | 0Source | 127,000Source |
| Income Taxes Paid, NetCNY | 0Source | 0Source | 0Source | 14,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 1,984,000Source | 21,320,000Source | 36,722,000Source | 47,379,000Source |
| Amortization of Intangible AssetsUSD | 20,000Source | 111,000Source | 274,000Source | 486,000Source |
| DepreciationUSD | 3,092,000Source | 7,040,000Source | 18,515,000Source | 17,506,000Source |
| Equity Method Investment, Other than Temporary ImpairmentCNY | 0Source | 34,000Source | — | — |
| Equity Method Investment, Realized Gain (Loss) on DisposalCNY | 0Source | 34,000Source | 51,000Source | 43,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -960,000Source | -14,000Source | -59,000Source | 225,000Source |
| Foreign Currency Transaction Gain (Loss), UnrealizedUSD | -869,000Source | — | — | — |
| Gain (Loss) on InvestmentsUSD | — | 729,000Source | 30,000Source | 15,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | 29,000Source | -301,000Source | -142,000Source | -206,000Source |
| General and Administrative ExpenseUSD | 18,031,000Source | 35,844,000Source | 61,666,000Source | 82,393,000Source |
| Income (Loss) from Equity Method InvestmentsCNY | 0Source | -13,000Source | -51,000Source | -43,000Source |
| Income Tax Expense (Benefit)USD | 223,000Source | 806,000Source | 336,000Source | 288,000Source |
| Net Income (Loss) Attributable to ParentUSD | -7,916,000Source | -47,489,000Source | -92,070,000Source | -140,815,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | -140,815,000Source |
| Operating Costs and ExpensesUSD | 65,459,000Source | 98,634,000Source | 145,431,000Source | 197,246,000Source |
| Proceeds from Contributed CapitalCNY | — | — | — | 0Source |
| Proceeds from Issuance of Long-term DebtUSD | 286,000Source | — | — | 0Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 77,157,000Source | 70,667,000Source | 75,696,000Source | 81,662,000Source |
| Cost of Goods and Services Sold | — | — | — | — |
| Operating Income (Loss)USD | -7,844,000Source | -48,987,000Source | -94,272,000Source | -142,145,000Source |
| Income Tax Expense (Benefit)USD | 223,000Source | 806,000Source | 336,000Source | 288,000Source |
| Net Income (Loss) Attributable to ParentUSD | -7,916,000Source | -47,489,000Source | -92,070,000Source | -140,815,000Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 20,000Source | 111,000Source | 274,000Source | 486,000Source |
| Current Income Tax Expense (Benefit)USD | 223,000Source | 806,000Source | 336,000Source | 288,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -960,000Source | -14,000Source | -59,000Source | 225,000Source |
| Gain (Loss) on InvestmentsUSD | — | 729,000Source | 30,000Source | 15,000Source |
| General and Administrative ExpenseUSD | 18,031,000Source | 35,844,000Source | 61,666,000Source | 82,393,000Source |
| Gross ProfitUSD | 57,615,000Source | 49,647,000Source | 51,159,000Source | 55,101,000Source |
| Income (Loss) from Equity Method InvestmentsCNY | 0Source | -13,000Source | -51,000Source | -43,000Source |
| Interest Income (Expense), NetUSD | -4,000Source | 0Source | 0Source | 15,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | -140,815,000Source |
| Operating Costs and ExpensesUSD | 65,459,000Source | 98,634,000Source | 145,431,000Source | 197,246,000Source |
| Other IncomeUSD | -37,000Source | 645,000Source | 68,000Source | 22,000Source |
| Research and Development ExpenseUSD | 23,808,000Source | 31,824,000Source | 48,876,000Source | 61,165,000Source |
| Selling and Marketing ExpenseUSD | 23,620,000Source | 26,154,000Source | 34,889,000Source | 53,688,000Source |